Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Advanced Cancer × Olanzapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Nausea 3 Vomiting 2 Neoplasms 2 Anorexia 2 Squamous Cell Carcinoma of Head and Neck 1 Prosthesis Failure 1 Opioid-Related Disorders 1 Nutrition Disorders 1 Multiple Myeloma 1 Hematologic Neoplasms 1 Cachexia 1 Advanced Cancer 1

Interventions

Rehabilitation 1 Paclitaxel 1 Oxaliplatin 1 Olanzapine 1 Nivolumab 1 Health Services Needs and Demand 1 Gemcitabine 1 Cisplatin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06338683 2024-03-29

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Qinghai Red Cross Hospital

Phase 3 Recruiting

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡